Billionaire David Tepper Sold Every Single Share of UnitedHealth in Q2. Here's Whether He Made a Costly Mistake.
2026-08-26 10:30
•Micah Zimmerman •The Motley Fool
•••••••• •••• Axe Cap view
Tepper’s UnitedHealth Exit: Sharp Move or Missed Opportunity?
David Tepper’s sale of UnitedHealth shares hints at a bet on AI over healthcare’s traditional winners.
David Tepper’s clean exit from UnitedHealth in Q2 to chase AI exposures raises questions, especially as UNH is quietly excelling in cost management. The company’s use of AI to streamline claims and control pricey GLP-1 drug costs is lifting margins from 4.6% to 7.1%, underscoring healthy earnings growth and resilience despite inflationary pressures. For South African investors, this matters because it reflects a broader theme: companies that embed AI to reduce operational costs could outperform without necessarily being pure tech plays. The JSE healthcare sector isn’t huge, but financial names like Sanlam and Old Mutual, which are adopting AI to streamline underwriting and claims, echo this trend. Tepper's focus on pure AI plays is understandable but perhaps premature if it means missing steady compounders benefiting from AI-driven efficiency gains. If the rand weakens unexpectedly on global USD strength, those US-based automation stories could soften local prospects, so watch USD/ZAR closely. this is just our opinion and not financial advice
Watch health-related and financial firms on the JSE integrating AI for cost control; consider adding Sanlam selectively. Avoid rushing into pure AI tech plays without a clear local growth story. Keep an eye on USD/ZAR for currency-driven risks.
- Sanlam
- USD/ZAR
- Stronger-than-expected rand appreciation hurting USD earnings translation
- US tech sell-off reducing appetite for AI stocks globally
6/10
Billionaire hedge fund manager David Tepper sold all 90,000 shares of UnitedHealth in Q2 to concentrate on AI investments. While medical cost pressures from GLP-1 drugs and inflation are real concerns, the article argues Tepper may have made a mistake, as UnitedHealth is actively managing costs through AI automation, workflow improvements, and strategic GLP-1 coverage policies. The company's operating margins improved and earnings growth remains strong, suggesting it's adapting well to healthcare industry changes.
Our take is based on reporting first published by The Motley Fool.
More stories like this
- SpaceX Just Announced a $100 Billion Starship Spaceport in Louisiana. Here's What It Means for Investors.
- Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.
- The Stock Market Faces a Critical Test on Wednesday -- Nvidia Earnings, Inflation, and GDP on the Same Day. Here’s What Investors Need to Know.